Peter Radovich insider trades: Mirum Pharmaceuticals (MIRM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Peter reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | MIRM | ↓ Sell | 16,515 | $91.98 | $1.5M | Direct | Mar 17, 2026 (1d) |
| Feb 2, 2026 | MIRM | ↓ Sell | 2,631 | $103.30 | $272K | Direct | Feb 3, 2026 (1d) |
| Jan 26, 2026 | MIRM | ↓ Sell | 3,143 | $96.19 | $302K | Direct | Jan 27, 2026 (1d) |
| Jan 22, 2026 | MIRM | ↓ Sell | 2,382 | $93.33 | $222K | Direct | Jan 23, 2026 (1d) |
| Mar 17, 2025 | MIRM | ↓ Sell | 7,879 | $44.21 | $348K | Direct | Mar 18, 2025 (1d) |
| Mar 4, 2025 | MIRM | ↓ Sell | 14,850 | $45.58 | $677K | Direct | Mar 5, 2025 (1d) |
| Feb 3, 2025 | MIRM | ↓ Sell | 2,627 | $48.22 | $127K | Direct | Feb 4, 2025 (1d) |
| Jan 24, 2025 | MIRM | ↓ Sell | 3,177 | $47.92 | $152K | Direct | Jan 27, 2025 (3d) |
| Jan 7, 2025 | MIRM | ↓ Sell | 1,998 | $42.82 | $86K | Direct | Jan 8, 2025 (1d) |
| Mar 25, 2024 | MIRM | ↓ Sell | 4,303 | $25.80 | $111K | Direct | Mar 25, 2024 (0d) |
| Feb 2, 2024 | MIRM | ↓ Sell | 1,790 | $26.19 | $47K | Direct | Feb 5, 2024 (3d) |
| Jan 8, 2024 | MIRM | ↓ Sell | 1,408 | $28.03 | $39K | Direct | Jan 9, 2024 (1d) |
| Jul 3, 2023 | MIRM | ↓ Sell | 1,425 | $25.65 | $37K | Direct | Jul 5, 2023 (2d) |
| Jan 9, 2023 | MIRM | ↓ Sell | 1,379 | $20.62 | $28K | Direct | Mar 18, 2024 (434d) |
| Oct 1, 2021 | MIRM | ↓ Sell | 1,364 | $19.26 | $26K | Direct | Oct 1, 2021 (0d) |
| Feb 1, 2018 | GBT | ↓ Sell | 812 | $57.30 | $47K | Direct | Feb 2, 2018 (1d) |
| Jan 23, 2018 | GBT | ↓ Sell | 30,000 | $60.00 | $1.8M | Direct | Jan 25, 2018 (2d) |
| Jan 10, 2018 | GBT | ↓ Sell | 15,000 | $50.00 | $750K | Direct | Jan 11, 2018 (1d) |
| Oct 30, 2017 | GBT | ↓ Sell | 12,500 | $35.00 | $438K | By Trust | Oct 31, 2017 (1d) |
| Aug 31, 2017 | GBT | ↓ Sell | 2,410 | $30.00 | $72K | Direct | Sep 5, 2017 (5d) |
| Aug 17, 2015 | GBT | ↑ Buy | 12,500 | $20.00 | $250K | Direct | Jan 7, 2016 (143d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MIRM insiders
Open-market trades in the last 12 months
About Peter Radovich's insider trades
Peter Radovich is President and COO at Mirum Pharmaceuticals (MIRM). Since Aug 17, 2015, Peter has reported 1 open-market purchase worth $250K and 20 sales worth $7.1M on SEC Form 4. In the last 12 months: 4 sales ($2.3M).
Their filings also include grants and awards (25 filings), option exercises (14 filings), shares withheld for taxes (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MIRM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.